SRI International Awarded Contract From National Institute Of Neurological Disorders And Stroke To Develop Chemical Agent Countermeasures

MENLO PARK, Calif.--(BUSINESS WIRE)--SRI International, an independent nonprofit research and development organization, today announced that it was awarded a $9.5 million contract by the National Institute of Neurological Disorders and Stroke (NINDS) to develop medical countermeasures to prevent, diagnose, and treat the conditions caused by potential and existing chemical agents of terrorism. This project is part of the National Institutes of Health (NIH) CounterACT program, a trans-NIH program to develop improved medical countermeasures for chemical threats that is led by NINDS.
MORE ON THIS TOPIC